PATENT CLAIM ANALYSIS

Application Number: 15925266
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-07
Patent Classification: ["514", "04400A"]

Abstract:
The present invention relates to antisense oligonucleotides that modulate the expression of and/or function of a Lipid transport and metabolism gene, in particular, by targeting natural antisense polynucleotides of a Lipid transport and metabolism gene. The invention also relates to the identification of these antisense oligonucleotides and their use in treating diseases and disorders associated with the expression of a Lipid transport and metabolism genes.

Claim (Index 4):
The oligonucleotide of  claim 1 , wherein said oligonucleotide comprises at least one phosphorothioate internucleotide linkage.

Metadata:
- Claim Count in Document: 10.0
- Percentile: 90.0
- Lexical Diversity: 1.76923
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14814895', '14815007', '13318713', '14723740', '14534323']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8646307792207863
- 35 USC 102 Novelty (BERT): 0.6959327705902197
- Combined Prediction Score: 0.8477609783577297
- Mean Citation Score: 666.82461
- Max Citation Score: 728.7385
- Similarity Product: 717.9962935197949

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test